Finally, we used immunohistochemistry to detect whether CXCR4 was highly expressed in GBM and assessed the expression level of CXCR4 by a semi-quantitative assessment method, and the results were similarly confirmed (Figure 8G). The gene discussed is CXCR4; the disease is glioblastoma.